In quick succession the FDA’s Office of Prescription Drug Promotion (OPDP) issued two Untitled Letters in recent weeks, the first since January. The first was sent July 17 to Kaleo, Inc., in Richmond, Va., alleging a lack of risk information in a sponsored Instagram post. “The post was made by Brittany Mahomes on her personal Instagram account in ‘Paid partnership with Auvi-... Read More